ArticleInternational journal of molecular sciences2026
Comment on Yamazaki et al. Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy.
Liliana Italia De Rosa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.